(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RAN BIOTECHNOLOGIES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RAN BIOTECHNOLOGIES

ST13

US500000087717701

Class

1

Filing

87717701

Registration

5528960

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

03/22/2024

Trademark type

Combined

Nice classes

1

Filing date

12/12/2017

Registration date

07/31/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/22/2024

Last transaction

03/22/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

03/08/2015

First use in commerce

03/08/2015

Drawing code

3

Owner type

03

Owner location

Beverly, MA, US

Examiner

LOVELACE, JAMES

Law office

N10

Current location

TMO LAW OFFICE 119

Mark description

The mark consists of four circles in white on an orange rectangular background, two of which are connected by a channel in white. The letters "RAN" appear in blue next to the rectangle and the term "BIOTECHNOLOGIES" is written in blue beneath the rectangle and "RAN" lettering.

Holders and representatives

Holders

RAN Biotechnologies, Inc.

Representatives

William E OBrien, Esq. OBrien Global Law

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Specialty chemicals for biotechnological applicationsfluorinated surfactants for use in such applications as droplet microfluidics and micro- and nano-materials in the nature of biotechnological chemicals for rapidly detecting biologicalslive microbes

Publications

History of USPTO decisions and trademark events.

28 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/22/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/22/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/22/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/27/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/27/2023

E815

TEAS SECTION 8 & 15 RECEIVED

09/26/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/31/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/31/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/15/2018

PUBO

PUBLISHED FOR OPPOSITION

05/15/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/25/2018

ALIE

ASSIGNED TO LIE

04/09/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

04/02/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/02/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

04/02/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/02/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/29/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/28/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/28/2018

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

03/23/2018

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

03/23/2018

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

03/23/2018

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

03/23/2018

DOCK

ASSIGNED TO EXAMINER

03/22/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/23/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/22/2017

Continuous trademark protection

Get notified about every new filing that threatens RAN BIOTECHNOLOGIES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.